{{Rsnum
|rsid=2964475
|Chromosome=5
|position=5407701
|Orientation=minus
|GMAF=0.4619
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene=LOC101929200
|Gene_s=LOC101929200
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 16.8 | 49.6 | 33.6
| HCB | 36.1 | 43.6 | 20.3
| JPT | 31.9 | 40.7 | 27.4
| YRI | 20.7 | 43.4 | 35.9
| ASW | 23.6 | 45.5 | 30.9
| CHB | 36.1 | 43.6 | 20.3
| CHD | 23.1 | 50.9 | 25.9
| GIH | 6.9 | 43.6 | 49.5
| LWK | 23.9 | 52.3 | 23.9
| MEX | 17.2 | 44.8 | 37.9
| MKK | 19.0 | 50.3 | 30.7
| TSI | 25.5 | 37.3 | 37.3
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=C
  |Pval=4E-6
  |OR=2.25
  |ORtxt=[1.592-3.174]
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}